Skip to main content
. Author manuscript; available in PMC: 2015 Sep 1.
Published in final edited form as: Gynecol Oncol. 2014 Jul 11;134(3):455–461. doi: 10.1016/j.ygyno.2014.07.002

Table 1.

Patient and Tumor Characteristics (N = 350)

Variable n (%)
Age (years)
    Median (range) 61 (34 – 86)
Primary site of disease
    Ovary 264 (75%)
    Fallopian tube 42 (12%)
    Peritoneal 44 (13%)
FIGO Stage
    III A/B 8 (2%)
    IIIC 248 (71%)
    IV 94 (27%)
Grade
    1 11 (3%)
    2 8 (2%)
    3 328 (94%)
    N/A 3 (1%)
Histology
    Serous 314 (90%)
    Endometrioid/Clear cell 2 (0.6%)
    Mixed/Other 34 (10%)
Preoperative CA-125 (U/mL)
    Median (range) 860 (9 – 38, 100)
ASA class
    1 10 (3%)
    2 158 (45%)
    3 178 (51%)
    4 3 (1%)
    N/A 1 (0.3%)

FIGO, International Federation of Gynecology and Obstetrics; ASA, American Society of Anesthesiologists